SANUWAVE Health Inc. (SNWV) — Financial statements
Income statement, balance sheet, and cash flow for SANUWAVE Health Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 44↑35.0% | 33↑60.0% | 20↑21.8% | 17↑28.7% | 13 | |
| Cost of Revenue | 10↑24.7% | 8↑34.0% | 6↑39.3% | 4↓13.1% | 5 | |
| Gross Profit | 34↑38.4% | 25↑70.9% | 14↑15.7% | 12↑54.7% | 8 | |
| Operating Expenses | ||||||
| R&D Expenses | 1↑101.0% | 0.67↑16.2% | 0.58↑2.1% | 0.57↓48.5% | 1 | |
| General & Administrative Expenses | 19↑70.7% | 11↑30.8% | 9↓30.9% | 13↑7.4% | 12 | |
| Selling & Marketing Expenses | 7↑17.3% | 6↑29.1% | 5↓34.5% | 7↓13.0% | 9 | |
| SG&A Expenses | 27↑51.6% | 18↑30.2% | 14↓32.2% | 20↓1.2% | 20 | |
| Other Expenses | 0.88↑11.5% | 0.79↑4.9% | 0.75↓1.8% | 0.77↓2.3% | 0.78 | |
| Operating Expenses | 29↑51.7% | 19↑28.4% | 15↓30.2% | 21↓3.6% | 22 | |
| Total Costs & Expenses | 39↑43.7% | 27↑30.0% | 21↓18.5% | 26↓5.4% | 27 | |
| Operating Results | ||||||
| Operating Income | 5↓8.7% | 5↑1103.1% | -0.54↑94.0% | -9↑36.7% | -14 | |
| Depreciation & Amortization | 1↑12.1% | 1↑11.4% | 1↑8.0% | 0.95↓23.0% | 1 | |
| EBITDA | 19↑217.3% | -17↓81.0% | -9↓290.9% | 5↑125.4% | -19 | |
| EBIT | 18↑202.5% | -18↓73.9% | -10↓365.0% | 4↑119.1% | -20 | |
| Interest & Other Income | ||||||
| Net Interest Income | -6↑54.2% | -14↑12.7% | -16↓10.6% | -14↓99.2% | -7 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 6↓54.2% | 14↓12.7% | 16↑10.6% | 14↑99.2% | 7 | |
| Non-Operating Income | -13↓157.1% | 23↑139.9% | 10↑175.4% | -13↓313.4% | 6 | |
| Other Income / Expenses | 7↑118.9% | -37↓45.5% | -25↓1786.7% | -1↑89.8% | -13 | |
| Income Before Tax | 12↑138.0% | -31↓21.5% | -26↓150.7% | -10↑62.2% | -27 | |
| Income Tax Expense | 0.09↑218.5% | 0.03↑575.0% | 0.00↑100.0% | 0.00↓92.9% | 0.03 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 12↑137.7% | -31↓21.6% | -26↓150.7% | -10↑62.2% | -27 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 12↑137.7% | -31↓21.6% | -26↓150.7% | -10↑62.2% | -27 | |
| Bottom-Line Net Income | 12↑137.7% | -31↓21.6% | -26↓150.7% | -10↑62.2% | -27 | |
| EPS (Basic) | 1.38↑119.6% | -7.03↑42.3% | -12.19↓73.6% | -7.02↑64.4% | -19.72 | |
| EPS (Diluted) | 0.41↑105.8% | -7.03↑42.3% | -12.19↓73.6% | -7.02↑64.4% | -19.72 | |
| Weighted Average Shares | 9↑91.9% | 4↑110.8% | 2↑44.5% | 1↑6.0% | 1 | |
| Weighted Average Diluted Shares | 9↑103.5% | 4↑110.8% | 2↑44.5% | 1↑6.0% | 1 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.